Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen.
Ott
R
R
Department of Surgery, University of Erlangen-Nuremberg, Germany.
Gralka
S
S
Froschauer
R
R
Born
G
G
Müller
V
V
Reck
T
T
Hohenberger
W
W
Köckerling
F
F
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006509:Hepatitis B / Q000601:surgery; D006526:Hepatitis C / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D008103:Liver Cirrhosis / Q000601:surgery; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000453:epidemiology; D008775:Methylprednisolone / Q000627:therapeutic use; D015166:Monitoring, Immunologic; D016609:Neoplasms, Second Primary / Q000453:epidemiology; D009894:Opportunistic Infections / Q000453:epidemiology; D011183:Postoperative Complications; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008775:Methylprednisolone